Recombinant pox virus for immunization against tumor-associated antigens

Details for Australian Patent Application No. 2003266471 (hide)

Owner Therion Biologics Corporation United States Government as represented by The Department Of Health And Human Services

Inventors Mazzara, Gail P.; Panicali, Dennis L.; Schlom, Jeffrey; Gritz, Linda R.

Agent Callinan

Pub. Number AU-A-2003266471

Parent 767562

Filing date 4 December 2003

Wipo publication date 15 January 2004

International Classifications

C12N 015/86 Mutation or genetic engineering - Viral vectors

Event Publications

18 December 2003 Complete Application Filed

15 January 2004 Application Open to Public Inspection

  Published as AU-A-2003266471

26 August 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003266472-Bioconversion of a fermentable carbon source to 1,3-propanediol by a single microorganism

2003266470-Gene encoding syntaxin interacting protein